| Financial Year |
March 31 2023 |
| Monetary Funds |
4,390,596,285.86 |
| Held-for-trading Financial Assets |
1,218,701,501.91 |
| Notes Receivable |
88,686,815.24 |
| Accounts Receivable |
6,630,910,079.28 |
| Advances to Suppliers |
125,269,283.89 |
| Other Receivables |
170,582,108.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,000,000.00 |
| Inventories |
4,524,326,185.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
791,626,999.81 |
| Total Current Assets |
18,230,926,491.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
670,347,328.89 |
| Investment Properties |
55,566,803.45 |
| Fixed Assetes |
9,661,560,070.83 |
| Under-construction Projects |
1,101,559,829.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,172,462,469.76 |
| R&D expenses |
29,460,275.64 |
| Goodwill |
1,366,907,020.09 |
| Long-Term Deferred and Prepaid Expenses |
703,713,560.06 |
| Deferred Income Tax Assets |
796,872,571.17 |
| Other Non-Current Assets |
544,818,622.32 |
| Sub-Total of Non-Current Assets |
16,936,470,567.98 |
| Total Assets |
35,167,397,059.65 |
| Short-Term Loans |
2,050,449,452.64 |
| Trading Financial liabilities |
20,765,811.90 |
| Notes Payable |
534,010,809.45 |
| Accounts Payable |
4,975,860,879.42 |
| Accounts Received In Advance |
651,306.09 |
| Employee Compensation Payable |
241,313,120.68 |
| Taxes Payable |
265,178,335.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
480,239,652.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,114,016,146.63 |
| Other Current Liabilities |
214,015,962.41 |
| Sub-Total of Current Liabilities |
10,920,731,672.73 |
| Long-term Loans |
4,357,546,797.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
260,508,352.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
351,617,960.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,309,273,931.31 |
| Total Liabilities |
17,230,005,604.04 |
| Paid-In Capital(Or Share Stock) |
1,763,821,545.19 |
| Capital Surplus |
8,848,866,858.45 |
| Surplus Reserve |
712,093,393.73 |
| LESS:Treasury Stock |
392,038,586.63 |
| Undistributed Profits |
6,867,588,782.11 |
| Minority Stockholder's Interest |
109,296,909.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,828,094,545.66 |
| Owner's Equity（Stockholder's Equity） |
17,937,391,455.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
35,167,397,059.65 |
